Filters
Other countries
Results: 1 to 13 of 13
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
DPYS - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Dihydropyrimidinase deficiency via the DPYS Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 414 | 800 |
|
Metabolic epilepsy panel. 41-gene NGS panel. Genologica Medica Spain | 53 | 41 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Dihydropyrimidinase Deficiency (DPYS Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Dihydropyrimidinase Deficiency Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD Netherlands | 1 | 1 |
|
Results: 1 to 13 of 13
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.